Plumb Pharmaceuticals has developed a platform technology for the extended release of medications into a patient’s system. Their first product will focus on improving opioid addiction treatment by doubling the release time of naltrexone. Plumb has refined two key formulations using a rat model and plans to move testing into a dog model before the end of the year. They are currently in the early stages of opening their next fundraising round.
Location: United States, Wisconsin, Madison